BHARAT PARENTERALS
|
The Current P/E Ratio of BHARAT PARENTERALS is 38.40.
Share Price | ₹1,436.4 | Nov 04,2024 |
Market Cap | ₹991.1 Cr | |
Earnings-TTM | ₹25.8 Cr | TTM-Standalone Results |
Price/Earnings | 38.40x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of BHARAT PARENTERALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹991.1 Cr] as on Nov 04,2024
(/) Earnings [ ₹25.8 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 38.40x ]
Thus, for BHARAT PARENTERALS , the investors are currently willing to pay 38.40 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BHARAT PARENTERALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BHARAT PARENTERALS over the last five years.
Historical PE (Price/Earnings) ratio chart of BHARAT PARENTERALS
PE Ratio Performance Analysis for BHARAT PARENTERALS
- BHARAT PARENTERALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 11.74x.
- BHARAT PARENTERALS 's operated at median p/e ratio of 9.25x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BHARAT PARENTERALS 's p/e ratio peaked in Mar2024 at 28.91x.
- BHARAT PARENTERALS 's p/e ratio hit its five-year low in Mar2020 of 3.09x.
How does BHARAT PARENTERALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
BHARAT PARENTERALS | 25.81 | 38.40 | 991.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.97 | 433,992.0 |
CIPLA LTD | 4,485.22 | 28.53 | 127,968.0 |
DR REDDYS LABORATORIES LTD | 5,549.00 | 19.07 | 105,796.0 |
ZYDUS LIFESCIENCES LTD | 4,181.90 | 24.17 | 101,056.0 |
DIVIS LABORATORIES LTD | 1,674.00 | 93.49 | 156,498.0 |
MANKIND PHARMA LTD | 1,976.25 | 55.45 | 109,574.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 60.07 | 108,250.0 |
LUPIN LTD | 2,287.78 | 43.64 | 99,847.4 |
AUROBINDO PHARMA LTD | 3,533.22 | 23.13 | 81,733.3 |
ABBOTT INDIA LTD | 1,238.99 | 50.52 | 62,599.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BHARAT PARENTERALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.07x |
Max industry PE | 93.49x |
Median industry PE | 38.97x |
Average industry PE | 43.22x |
You may also like the below Video Courses